Trending News
Search results for: "Weight loss". 6 articles found.
An expanding body of research indicates that these anti-obesity drugs may also work for the disorder known as PMOS...
US Weekly - 12 hours 44 min agoThe Real Housewives of Orange County star Emily Simpson is opening up about her altered approach to using GLP-1 medications to lose weight. "I do still [use a GLP-1, but] not much as I did," Emily, 50, exclusively told Us on Friday, August 14. "I use it now to just kind of, like, maintain. So I'll go a few weeks and not use it, and then I'll feel like I'm starting to gain weight and then I'll use it again." She continued. "So instead of doing it weekly —...
Serena Williams' choice to take GLP-1 medication for weight loss continues to be her comeback narrative. So far, it hasn't received the public appreciation that RO, a company for which the American tennis icon is an ambassador, would've liked.
Users need discretionary income of nearly 100,000 a year to make savings on their grocery spend after paying 1,200 for GLP-1s, analysis finds The high cost of weight-loss medication is a "regressive tax on being thin" because the outlay outweighs any saving on food costs for all but the highest earners. Someone needs to have discretionary income of nearly 100,000 a year to actually save money after covering the 1,200 annual cost of GLP-1 medication, according to an analysis by the consultancy...
For more than half a decade, Chrissy Metz was determined to avoid the big three. As in Ozempic, Mounjaro, Wegovy... Of course, the list of GLP-1 weight loss injectables and the public's ability...
Scientists have uncovered why two seemingly opposite ways of targeting the same brain receptor can both promote weight loss. In mice, activating the GIP receptor in the brainstem reduced appetite, while blocking it in the hypothalamus removed a kind of "brake" on fullness signals. The discovery helps explain why very different obesity drugs can achieve similar results and suggests that carefully combining GIP-targeting treatments with GLP-1 drugs like those related to Wegovy and Ozempic...
GET IN TOUCH
About
Snips is the first performance-based influencer marketing platform that empowers influencers with business tools to grow their audience and monetize their social networks, while enabling brands to run performance-driven influencer programs built on true measurability & scale.